Litigating biotech patents in Europe

This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight

Litigation around Europe relating to biotechnology patents is likely to increase significantly over the coming years as biologics form an increasing number of newly approved medicines. Two high-profile biotech cases have just been heard by the UK patents court: Monsanto v Cargill [2007] EWHC 2257 and Eli Lilly v HGS (judgment awaited).


Unlock unlimited access to all IAM content